SeaCrest Wealth Management LLC Grows Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

SeaCrest Wealth Management LLC lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,480 shares of the healthcare conglomerate’s stock after acquiring an additional 380 shares during the period. SeaCrest Wealth Management LLC’s holdings in UnitedHealth Group were worth $1,870,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Robbins Farley acquired a new position in shares of UnitedHealth Group during the 3rd quarter valued at $25,000. Richelieu Gestion SA purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth about $26,000. CGC Financial Services LLC raised its holdings in shares of UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after buying an additional 50 shares during the period. NewSquare Capital LLC boosted its holdings in UnitedHealth Group by 340.0% in the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 51 shares during the period. Finally, Strategic Investment Solutions Inc. IL purchased a new stake in shares of UnitedHealth Group during the first quarter valued at approximately $35,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on UNH shares. Stephens reaffirmed an “overweight” rating and set a $605.00 price target on shares of UnitedHealth Group in a research note on Thursday, February 8th. Barclays started coverage on UnitedHealth Group in a report on Wednesday, March 6th. They issued an “overweight” rating and a $551.00 price target for the company. Piper Sandler cut their target price on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 17th. HSBC reissued a “reduce” rating and set a $480.00 price target (down previously from $550.00) on shares of UnitedHealth Group in a research report on Monday, December 18th. Finally, Oppenheimer reissued an “outperform” rating and set a $610.00 price objective on shares of UnitedHealth Group in a report on Wednesday, January 17th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $579.33.

Insider Transactions at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company’s stock.

UnitedHealth Group Stock Performance

UnitedHealth Group stock traded up $1.60 during mid-day trading on Thursday, hitting $494.70. 3,805,551 shares of the company’s stock traded hands, compared to its average volume of 4,097,774. UnitedHealth Group Incorporated has a one year low of $445.68 and a one year high of $554.70. The company has a market cap of $456.08 billion, a PE ratio of 20.70, a price-to-earnings-growth ratio of 1.34 and a beta of 0.54. The firm has a 50 day moving average price of $503.10 and a 200 day moving average price of $518.61. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.62.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, beating the consensus estimate of $5.98 by $0.18. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The firm had revenue of $94.43 billion for the quarter, compared to analysts’ expectations of $92.13 billion. During the same quarter last year, the company earned $5.34 EPS. UnitedHealth Group’s quarterly revenue was up 14.1% on a year-over-year basis. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 27.82 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio is currently 31.54%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.